April 24, 2013 – Dr. McAllister presented Cytograft's clinical progress at the American Heart Association's Emerging Science Series "Innovations in Vascular Bioengineering"
• Webinar recording available HERE.
April 17, 2013 - Dr. L’Heureux presented a webinar for young professionals on "Developing an Industry Career in Biomedical Engineering". More information available via BMES.
April 10, 2013 –
Society for Biomaterials 2013 Annual Meeting- Adam Young presented on work creating dermal fillers using Cytograft's TESA technology.
December 8, 2012 - Dr. L’Heureux was invited to Tianjin to speak at the International Symposium on Small Diameter Vascular Grafts.
April 23, 2012 – Dr. L’Heureux reports a new process with cell synthesized threads at the annual FASEB meeting.
• Press release can be found HERE.
• Scientific American story HERE.
• MIT Technology Review HERE.
Cytograft's vision is to revolutionize cardiovascular medicine by developing cell-based therapies to repair and rebuild diseased tissues and organs without using synthetic biomaterials.
Cytograft's CSO and inventor of Tissue Engineering by Self-Assembly, Dr. Nicolas L'Heureux, explains the Lifeline™ Technology